Relieving Pain or Causing Pain?
Darvon Info from our South Carolina Injury Lawyers
With any prescription medication, there are side effects. These may range from drowsiness to stomach irritation, but the positive effects of the medication usually outweigh the negatives. However, the South Carolina injury attorneys at McGowan, Hood & Felder, LLC found information about a prescription medicine whose newly discovered side effects caused it to be pulled from the market. You should be aware that this defective drug Darvon, or Darvocet, might have negatively affected you or a loved one.
Darvon and Darvocet, the brand-name versions of the prescription pain medication propoxyphene, have been withdrawn from the United States pharmaceutical market at the request of the U.S. Food and Drug Administration (FDA). The FDA has also informed the generic manufacturers of propoxyphene-containing products and requested that they voluntarily remove their products as well. Recent studies show that these drugs can cause serious medical problems, including heart arrhythmias.
Information about Darvon and Darvocet
Propoxyphene is an opioid used to treat mild to moderate pain. In July 2009, the FDA required the manufacturer of Darvon/Darvocet to conduct a new safety study assessing unanswered questions about the effects of propoxyphene on the heart. The FDA reviewed the data from that study, which show that even when taken at recommended doses, propoxyphene causes significant changes to the electrical activity of the heart. These changes, as seen on an electrocardiogram (ECG), can increase the risk for significant abnormal heart rhythms that linked to serious adverse effects, including sudden death.
The FDA sought market withdrawal of propoxyphene after receiving new clinical data showing that the drug puts patients at risk of potentially serious or even fatal heart rhythm abnormalities. This data, combined with other information including new epidemiological data, caused the agency to conclude that the risks of the medication outweigh the benefits.
The FDA is advising health care professionals to stop prescribing Darvon, Darvocet and their generic equivalents. In addition, patients who are currently taking the drug should contact their health care professional as soon as possible to discuss switching to another pain management therapy.
McGowan, Hood & Felder, LLC is now pursuing cases involving Darvon and Darvocet. If you know of anyone who may have suffered personal injuries or death because of using any brand of a propoxyphene-containing product, contact our experienced South Carolina injury lawyers immediately for a free consultation. Your life is our mission.